| Product |
CAS |
Molecular formula |
More |
| Piperazine, 1-[(4-fluorophenyl)sulfonyl]-4-(1-methyl-1h-benzimidazol-2 |
604741-58-4 |
C18H19FN4O2S |
More |
| Piperazine, 1-[(4-hydroxy-3-quinolinyl)carbonyl]-(9ci) |
604772-60-3 |
|
More |
| Piperazine, 1-[(4-hydroxy-6,8-dimethoxy-3-quinolinyl)carbonyl]-4-methy |
604772-71-6 |
|
More |
| Oxazole, 4,5-dihydro-4-(1-methylethyl)-2-(2-methylpropyl)-, (s)-(9ci) |
175226-81-0 |
C10H19NO |
More |
| Piperazine, 1-[(4-hydroxy-8-methyl-3-quinolinyl)carbonyl]-(9ci) |
604773-39-9 |
C15H17N3O2 |
More |
| Oxazole, 4,5-dihydro-4-(1-methylethyl)-2-[(methylthio)methyl]-, (s)-(9 |
154260-41-0 |
C8H15NOS |
More |
| Piperazine, 1-[(4-methoxyphenyl)sulfonyl]-4-(1-methyl-1h-benzimidazol- |
604741-60-8 |
C19H22N4O3S |
More |
| Oxazole, 4,5-dihydro-4-(1-methylethyl)-2-propyl-, (4s)-(9ci) |
253686-05-4 |
C9H17NO |
More |
| Oxazole, 4,5-diisopropyl-(5ci) |
797802-16-5 |
C9H15NO |
More |
| Oxazole, 4-bromo-5-ethoxy-2-ethyl-(9ci) |
284040-96-6 |
C7H10BrNO2 |
More |
| Oxazole, 4-bromo-5-ethoxy-2-methyl-(9ci) |
284040-93-3 |
C6H8BrNO2 |
More |
| Piperazine, 1-[(5-methyl-3-pyridinyl)methyl]-(9ci) |
182354-90-1 |
C11H17N3 |
More |
| Piperazine, 1-[(6,12-dihydro-4-methoxy-6,12-dioxoindolo[2,1-b]quinazol |
169038-55-5 |
C21H20N4O5S |
More |
| Oxazole, 4-butyl-2-ethyl-4,5-dihydro-5-methyl-5-(2-propenyl)-(9ci) |
205745-13-7 |
C13H23NO |
More |
| Piperazine, 1-[(6-ethoxy-4-hydroxy-3-quinolinyl)carbonyl]-(9ci) |
604773-10-6 |
C16H19N3O3 |
More |
| Oxazole, 4-cyclopentyl-4,5-dihydro-2-methyl-, (4r)-(9ci) |
223473-38-9 |
C9H15NO |
More |
| Piperazine, 1-[(6-ethoxy-4-hydroxy-3-quinolinyl)carbonyl]-4-ethyl-(9ci |
604773-05-9 |
C18H23N3O3 |
More |
| Oxazole, 4-ethoxy-5-hexyl-4,5-dihydro-5-methyl-(9ci) |
128101-14-4 |
C12H23NO2 |
More |
| Piperazine, 1-[(6-ethoxy-4-hydroxy-3-quinolinyl)carbonyl]-4-methyl-(9c |
604772-99-8 |
C17H21N3O3 |
More |
| Oxazole, 4-ethyl-4,5-dihydro-2-(2-phenylethenyl)-(9ci) |
246240-63-1 |
C13H15NO |
More |
